NARA
PanGenomic Health Inc
Access
ISIN
CA69842E2050
Bid
2.00
Mid
2.50
Ask
3.00
Key Information
- Price Change
- 0.00%
- Year High
- 4.50
- Year Low
- 2.50
- Last Trade
- 30 Nov 23
- Market Cap
- £2.62M
- Par
- 0.00
- Bid
- 2.00
- Mid Price
- 2.50
- Ask
- 3.00
- Instrument Type
- Ordinary Shares
- MIFID Status
- MTF
- Tradable Securities
- 105.0M
- Sector
- Healthcare
Prices in GBX except for Market Cap in GBP
About PanGenomic Health Inc
The Company is a precision health company that has developed a self-care digital platform to deliver personalised, evidence-based information about natural treatments to support mental health. The Company has three platforms: Nara App - a mental health mobile app which provides consumers with a knowledge base tailored to an individual's unique user profile, developed by tracking a user's treatment regimen and their specific genomic, proteomics and microbiomic data. indleap.com - and app and telehealth platform for holistirc mental wellness which grants users access to great audio content and blogs, a mental health tracker, and access to professional services for mental well-being. The Company's digital therapeutics clinic platform, the PlantGx Platform, provides health practitioners with access to a consumer's Nara App data in order to assist them to optimize the identification of appropriate natural remedies and monitor a patient's prognosis during treatment. Mindleap.com was acquired in November 2022 when the Company purchased the entire issued share capital for Mindleap Health Inc from Mydecine Innovations Group Inc.
Latest Trades
Date | Volume | Price (GBX) | Value (GBP) |
---|---|---|---|
30 Nov 23 16:04 | 12,500 | 3.00 | 375.00 |
30 Nov 23 16:04 | 12,500 | 3.00 | 375.00 |
30 Nov 23 15:55 | 12,500 | 3.50 | 437.50 |
30 Nov 23 15:54 | 12,500 | 3.50 | 437.50 |
30 Nov 23 15:53 | 12,500 | 3.50 | 437.50 |
Latest Announcements & Notices
Date | Title |
---|---|
30 Nov 23 07:05 | PanGenomic Health Inc - PanGenomic Health Announces Q3 Financial Results |
30 Nov 23 07:00 | PanGenomic Health Inc - Total Voting Rights |
17 Nov 23 12:30 | PanGenomic Health Inc - PanGenomic Health Subsidiary Announces First Sale of BDNF Biomarker Tests |
02 Nov 23 09:47 | PanGenomic Health Inc - PanGenomic Health Intends to Close Shares for Debt Settlement |
12 Apr 23 01:00 | Market Notice - Admission to Trading |
Address
Registered Address
232 – 3800 Wesbrook Mall, Vancouver, British Columbia, V6S 2L9, CanadaPhone
604-218-5788
Contacts
Corporate Adviser
Novum Securities, 2nd Floor, 7-10 Chandos Street, London, W1G 9DQ, United KingdomRegistrar
Link Group, 10th Floor, Central Square, 29 Wellington Street, Leeds, LS1 4DL, United Kingdom